Brief: Suven Pharmaceuticals March Quarter Consol Profit Falls
June 18 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* SUVEN PHARMACEUTICALS - MARCH QUARTER CONSOL NET PROFIT
741.8
MILLION RUPEES VERSUS 748.2 MILLION RUPEES
* SUVEN PHARMACEUTICALS - MARCH QUARTER CONSOL REVENUE FROM
OPERATIONS 1.85 BILLION RUPEES VERSUS 2.51 BILLION RUPEES
Source text for Eikon: ID:nBSE58cYKr
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss